Clinical Trial Update: Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays? [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating glucarpidase after methotrexate in bone sarcomas was terminated; the update discusses whether this approach could reduce side effects a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Spindle Cell Sarcoma of Bone

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Voraxaze (glucarpidase)

Snippet

Sponsor: University College, London | Conditions: Osteosarcoma, Spindle Cell Sarcoma of Bone | Phase 2 | Status: TERMINATED